Android app Apple app link

Viridian Therapeutics, Inc. (VRDN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$33.00

$0.57 (-1.7%)
Last update: 03:20 AM EST
Day's range
$31.34
Day's range
$33.51

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/28/2026 Evercore ISI Gavin Clark-Gartner $45.00 $33.14   35.79%
01/20/2026 Evercore ISI Gavin Clark-Gartner $44.00 $32.63   34.85%
11/05/2025 Stifel Nicolaus Alex Thompson $48.00 $24.24   98.02%
10/21/2025 H.C. Wainwright Douglas Tsao $34.00 $24.09   41.14%
11/12/2024 Stifel Nicolaus Alex Thompson $41.00 $11.41   259.33%
09/13/2024 RBC Capital Gregory Renza $44.00 $10.35   325.12%
09/11/2024 Needham Serge Belanger $38.00 $9.51   299.58%
09/11/2024 B.Riley Financial Kalpit Patel $22.00 $19.24   14.35%
09/10/2024 Stifel Nicolaus Alex Thompson $40.00 $8.68   360.83%
09/10/2024 BTIG Julian Harrison $56.00 $8.64   548.15%
08/14/2024 Goldman Sachs Richard Law $25.00 $14.18   76.3%
06/11/2024 RBC Capital Gregory Renza $35.00 $6.48   440.12%
06/11/2024 BTIG Julian Harrison $46.00 $6.48   609.88%
06/10/2024 Wolfe Research Andy Chen $29.00 $6.11   374.63%
06/06/2024 Goldman Sachs Richard Law $23.00 $6.17   272.77%
05/09/2024 Oppenheimer Leland Gershell $31.00 $7.45   316.11%
05/09/2024 H.C. Wainwright Douglas Tsao $27.00 $7.45   262.42%
05/08/2024 B.Riley Financial Kalpit Patel $20.00 $14.90   34.23%

Viridian Therapeutics, Inc. FAQ's

Viridian Therapeutics, Inc. has been rated by research analysts at Evercore ISI, UBS, William Blair, Truist Financial, RBC Capital, Goldman Sachs in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.